RAVER2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.206000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.012600E-01
Normal-vs-Stage2
4.408400E-01
Normal-vs-Stage3
7.896400E-01
Normal-vs-Stage4
1.154440E-01
Stage1-vs-Stage2
5.146400E-01
Stage1-vs-Stage3
4.426600E-01
Stage1-vs-Stage4
8.415000E-01
Stage2-vs-Stage3
5.260200E-01
Stage2-vs-Stage4
4.068000E-01
Stage3-vs-Stage4
2.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.539400E-01
Normal-vs-AfricanAmerican
1.549430E-01
Normal-vs-Asian
2.747400E-01
Caucasian-vs-AfricanAmerican
6.479800E-02
Caucasian-vs-Asian
3.883400E-01
AfricanAmerican-vs-Asian
3.801400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.422800E-01
Normal-vs-Female
4.090400E-01
Male-vs-Female
5.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.106600E-01
Normal-vs-Age(41-60Yrs)
2.883800E-01
Normal-vs-Age(61-80Yrs)
4.708800E-01
Normal-vs-Age(81-100Yrs)
6.801200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.524800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.314000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.873600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.434400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.334200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.254800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.955800E-01
Normal-vs-Daily Drinker
5.683200E-01
Normal-vs-Weekly Drinker
8.775800E-01
Normal-vs-Occasional Drinker
3.556000E-01
Normal-vs-Social Drinker
3.644200E-01
Non Drinker-vs-Daily Drinker
3.974800E-01
Non Drinker-vs-Weekly Drinker
1.130620E-01
Non Drinker-vs-Occasional Drinker
9.354000E-01
Non Drinker-vs-Social Drinker
9.570400E-01
Daily Drinker-vs-Weekly Drinker
3.901400E-01
Daily Drinker-vs-Occasional Drinker
3.257200E-01
Daily Drinker-vs-Social Drinker
4.180400E-01
Weekly Drinker-vs-Occasional Drinker
1.073580E-01
Weekly Drinker-vs-Social Drinker
1.309810E-01
Occasional Drinker-vs-Social Drinker
8.828400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.654100E-02
Normal-vs-Grade 2
4.801800E-02
Normal-vs-Grade 3
1.901750E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.651600E-01
Grade 1-vs-Grade 3
3.071800E-01
Grade 1-vs-Grade 4
4.654100E-02
Grade 2-vs-Grade 3
2.700600E-01
Grade 2-vs-Grade 4
4.801800E-02
Grade 3-vs-Grade 4
1.901750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.405000E-01
Normal-vs-NonDiabetic
3.503200E-01
Diabetic-vs-NonDiabetic
2.716200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.060400E-01
Normal-vs-NoPancreatitis
4.732000E-01
Pancreatitis-vs-NoPancreatitis
6.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.975800E-01
Normal-vs-N1
3.673000E-01
N0-vs-N1
5.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.791000E-01
Normal-vs-TP53-NonMutant
2.204200E-01
TP53-Mutant-vs-TP53-NonMutant
5.887800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
